Antibiotics resistance a 'catastrophic' global threat, UK warns

Resistance to antibiotics is a 'catastrophic' global threat and should be ranked alongside terrorism as one of the biggest risks Britain faces, the government's chief medical officer said Monday.

Sally Davies called the problem a "ticking time-bomb", saying routine hip operations could become deadly within 20 years if humans lose the ability to fight infections.

She said the issue should be put on the government's national risk register, which also includes "catastrophic " and other civil emergencies.

The knighted professor urged Britain to raise the issue at a G8 foreign ministers' meeting in London next month.

"Antimicrobial resistance is a ticking time-bomb not only for the UK but also for the world," Davies said.

"We need to work with everyone to ensure the apocalyptic scenario of widespread antimicrobial resistance does not become a reality.

"This threat is arguably as important as for the world."

She added: "Antimicrobial resistance poses a catastrophic threat. If we don't act now, any one of us could go into hospital in 20 years for and die because of an ordinary infection that can't be treated by .

"Governments and organisations across the world, including the and G8, need to take this seriously."

She said there had been a "discovery void" in the field since 1987 and called for more innovation around antibiotics, saying diseases had evolved faster than the drugs to treat them.

Davies said infection was estimated to be costing England £30 billion ($45 billion, 35 billion euros) per year in state health service costs and the cost of missed days at work.

Britain's Department of Health said it will soon publish its Antimicrobial Resistance Strategy five-year action plan.

add to favorites email to friend print save as pdf

Related Stories

A world without antibiotics?

Apr 07, 2011

Imagine a world without antibiotics. Common infections are life threatening. Pneumonia, urinary tract infections and venereal diseases are incurable. Cancer chemotherapies do not exist. The life expectancy for Canadian men ...

The rising threat of antibiotic resistance

Jan 10, 2013

A major European and global health issue is resistance to or inappropriate use of antibiotics. The European Centre for Disease Prevention and Control (ECDC) estimates that each year, antimicrobial resistance ...

Recommended for you

Evidence-based recs issued for systemic care in psoriasis

5 hours ago

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

6 hours ago

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

6 hours ago

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

Discovery of genes that predispose a severe form of COPD

9 hours ago

A study by Ramcés Falfán-Valencia, researcher at the National Institute of Respiratory Diseases (INER), found that the mestizo Mexican population has a number of variations in certain genes that predispose ...

On the environmental trail of food pathogens

10 hours ago

Tracking one of the deadliest food contamination organisms through produce farms and natural environments alike, Cornell microbiologists are showing how to use big datasets to predict where the next outbreak could start.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.